Market Tracker

04/01 6:02pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
5.89 -0.09 / -1.51%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.89 0.00 / 0.00%
 
Volume: 6.0K

Today’s Trading

Previous close5.98
Today’s open5.93
Day’s range5.63 - 5.97
Volume910,085
Average volume (3 months)875,384
Market cap$416.4M
Dividend yield--
Data as of 3:59pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-983.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio91.1
Price/Sales11.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.17-1.47%
ASNDAscendis Pharma A/S+0.08+0.46%
PTXPernix Therapeutics ...-0.11-1.03%
XOMAXOMA Corp-0.08-2.20%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts